查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873188

全球細胞檢測市場

Cell Based Assays
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年，全球基於細胞的檢測市場規模將達到421億美元。

全球細胞檢測市場規模預計在2024年為285億美元，到2030年將達到421億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為6.7%。藥物發現應用是本報告分析的細分市場之一，預計在分析期結束時將以6.5%的複合年成長率成長，達到190億美元。 ADME（吸收、分佈、代謝和排泄）研究應用細分市場預計在分析期內將以7.4%的複合年成長率成長。

美國市場規模估計為79億美元，而中國市場預計將以6.5%的複合年成長率成長。

預計到2024年，美國細胞檢測市場規模將達到79億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到66億美元，2024年至2030年的複合年成長率（CAGR）為6.5%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率將分別達到6.2%和5.4%。在歐洲，德國的複合年成長率預計約為5.5%。

全球細胞檢測市場—關鍵趨勢與促進因素概述

基於細胞的檢測方法如何革新藥物發現和生物醫學研究？

基於細胞的檢測方法為研究細胞功能、反應和交互作用提供了一種更動態、更生物學相關性的方式，並已成為藥物發現和生物醫學研究的基礎。與通常使用分離蛋白質或酵素的傳統生化檢測方法不同，基於細胞的檢測方法能夠全面展現化合物在活細胞內的相互作用，並可測量包括細胞增殖、細胞毒性、受體訊號傳導和基因表現的多種生物活性。這種方法在藥物篩檢中尤其重要，它使研究人員能夠在高度模擬人體環境的條件下即時評估新化合物的療效和安全性。這些檢測方法在識別有前景的候選藥物和闡明其作用機制方面發揮關鍵作用，顯著降低了藥物發現和開發所需的時間和成本。因此，製藥公司和研究機構高度依賴基於細胞的檢測方法來簡化研發流程，並更快地將更有效的療法推向市場。

為什麼各行各業對基於細胞的檢測方法的需求不斷成長？

在藥物研發、毒性測試和個人化醫療等領域的應用推動下，各行各業對基於細胞的檢測方法的需求正在迅速成長。在製藥業，由於需要更精確地預測人體生物學的模型，基於細胞的檢測方法被廣泛用於大型化合物庫的高通量篩檢(HTS)。這些檢測方法能夠快速識別潛在的候選藥物，並降低後期臨床試驗失敗的風險。在化妝品和化學產業，日益成長的監管壓力促使人們尋求替代動物測試的方法，從而推動了基於細胞的檢測方法在安全性和毒性測試中的應用。這些體外方法不僅提供了符合倫理的替代方案，還能提供關於物質對人體健康影響的更相關數據。此外，個人化醫療的興起（即為每位患者量身定做治療方法）進一步推動了對基於細胞的檢測方法的需求，因為這些方法使研究人員能夠研究患者獨特的細胞並預測其對特定藥物的反應。各行業對基於細胞的檢測方法的日益依賴凸顯了其在推進科學研究和開發更安全、更有效的產品方面的重要作用。

科技進步如何推動細胞檢測技術的創新？

技術創新正在革新基於細胞的檢測方法，顯著提升其準確性、效率和擴充性。高通量篩檢(HTS) 平台的創新使得平行分析數千種化合物成為可能，大大加速了藥物發現進程。自動化系統和機器人技術的整合提高了檢測執行和資料收集的準確性，減少了人為誤差和變異性。此外， 3D細胞培養技術的進步徹底改變了基於細胞的檢測方法，使研究人員能夠在3D空間中培養細胞，更接近模擬人體組織的自然環境。這些 3D 模型能夠更準確地了解細胞對藥物和毒素的反應，使其在腫瘤學和再生醫學研究中具有特別重要的價值。此外，電阻測量和即時細胞分析等無標定檢測技術也日益受到關注，因為它們無需外部染色劑或標記物，即可實現對細胞反應的連續監測。人工智慧 (AI) 和機器學習在數據分析中的應用也推動了創新，使研究人員能夠更有效地分析複雜的資料集，並識別出以前可能被忽略的趨勢。這些技術進步正在拓展基於細胞的檢測方法的可能性邊界，使其成為更強大的科學發現工具。

哪些因素正在推動基於細胞的檢測市場成長？

細胞檢測市場的成長受多種因素驅動，包括藥物發現過程日益複雜、生物技術不斷進步以及對預測性和個人化醫療的需求日益成長。其中一個關鍵促進因素是藥物篩檢中對生物相關模型的需求不斷增加。隨著製藥公司尋求降低臨床試驗的高失敗率，細胞檢測能夠更精確地模擬體內環境，有助於提高藥物療效和安全性預測的準確性。生物製藥和生物相似藥在製藥業的擴張也推動了對細胞檢測的需求，以測試這些複雜的分子，因為它們通常以傳統生化檢測無法捕捉的方式與活細胞相互作用。諸如3D細胞培養技術和無標定檢測方法等技術創新透過提高這些檢測的生理相關性和效率，進一步推動了市場成長。此外，向個人化醫療的轉變也推動了對可為每位患者量身定做的檢測的需求，從而實現更精準的治療策略。在監管方面，減少動物測試的呼聲日益高漲，加速了基於細胞的檢測方法在安全性和毒性測試中的應用，尤其是在化妝品和化學工業。此外，慢性病和癌症發病率的不斷上升也推動了疾病機制的研究與開發，進一步促進了醫療保健和生命科學產業基於細胞的檢測方法市場的成長。

部分：

組件（耗材、儀器、軟體、服務）、應用（藥物發現、ADME 研究、預測毒理學和其他應用）和最終用戶（製藥和生物技術公司、CRO（受託研究機構）、學術和政府機構以及其他最終用戶）。

受訪公司範例

  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Global Industry Analysts 並沒有查詢通用的 LLM 或產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對區域市場的影響，正如全球產業分析師預測的那樣，關稅將改變企業的競爭地位，而企業的競爭地位將取決於其總部所在地、製造地以及進出口（成品和OEM產品）。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP10937

Global Cell Based Assays Market to Reach US$42.1 Billion by 2030

The global market for Cell Based Assays estimated at US$28.5 Billion in the year 2024, is expected to reach US$42.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.0 Billion by the end of the analysis period. Growth in the ADME Studies Application segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 6.5% CAGR

The Cell Based Assays market in the U.S. is estimated at US$7.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Cell Based Assays Market - Key Trends and Drivers Summarized

How Are Cell-Based Assays Revolutionizing Drug Discovery and Biomedical Research?

Cell-based assays have become a cornerstone in drug discovery and biomedical research, offering a more dynamic and biologically relevant way to study cellular functions, responses, and interactions. Unlike traditional biochemical assays, which often use isolated proteins or enzymes, cell-based assays provide a comprehensive view of how a compound interacts within a living cell, allowing for the measurement of a broad range of biological activities, including cell proliferation, cytotoxicity, receptor signaling, and gene expression. This approach is particularly valuable in drug screening, where researchers can assess the efficacy and safety of new compounds in real-time, under conditions that closely mimic the human body. These assays play a crucial role in identifying promising drug candidates and understanding mechanisms of action, significantly reducing the time and cost associated with drug development. As a result, pharmaceutical companies and research institutions rely heavily on cell-based assays to streamline their R&D processes and bring more effective therapeutics to market faster.

Why Is the Demand for Cell-Based Assays Increasing Across Multiple Industries?

The demand for cell-based assays is rapidly increasing across a wide range of industries, driven by their applications in drug discovery, toxicity testing, and personalized medicine. In the pharmaceutical industry, the need for more accurate and predictive models of human biology has led to the widespread adoption of cell-based assays for high-throughput screening (HTS) of large compound libraries. These assays allow for the rapid identification of potential drug candidates while reducing the risk of failure in later stages of clinical trials. In the cosmetics and chemical industries, the growing regulatory pressure to replace animal testing has propelled the use of cell-based assays for safety and toxicity testing. These in vitro methods not only provide ethical alternatives but also offer more relevant data on how substances may affect human health. Additionally, the rise of personalized medicine, which focuses on tailoring treatments to individual patients, has further spurred demand for cell-based assays, as they enable researchers to study patient-specific cells and predict responses to specific drugs. This growing reliance on cell-based assays across industries highlights their critical role in advancing scientific research and improving the development of safer, more effective products.

How Are Technological Advancements Driving Innovation in Cell-Based Assays?

Technological advancements are revolutionizing cell-based assays, enhancing their accuracy, efficiency, and scalability. Innovations in high-throughput screening (HTS) platforms have made it possible to analyze thousands of compounds in parallel, significantly accelerating the drug discovery process. The integration of automated systems and robotics has improved the precision of assay execution and data collection, reducing human error and variability. Furthermore, advancements in 3D cell culture techniques have transformed the landscape of cell-based assays by allowing researchers to grow cells in three dimensions, which more closely mimics the natural environment of human tissues. These 3D models provide more accurate insights into how cells respond to drugs or toxins, making them particularly valuable in oncology and regenerative medicine research. Additionally, label-free detection technologies, such as impedance-based measurements and real-time cell analysis, are gaining traction, as they allow for the continuous monitoring of cellular responses without the need for external dyes or markers. The integration of artificial intelligence (AI) and machine learning into data analysis is also driving innovation, enabling researchers to analyze complex datasets more effectively and identify trends that may have otherwise gone unnoticed. These technological advancements are pushing the boundaries of what is possible with cell-based assays, making them more powerful tools for scientific discovery.

What Are the Factors Driving Expansion of the Cell-Based Assay Market?

The growth in the cell-based assay market is driven by several factors, including the increasing complexity of drug discovery, advancements in biotechnology, and the growing need for predictive and personalized medicine. One of the key drivers is the rising demand for more biologically relevant models in drug screening. As pharmaceutical companies seek to reduce the high attrition rates in clinical trials, cell-based assays offer a more accurate representation of in vivo conditions, leading to better predictions of a drug’s efficacy and safety. The expansion of biologics and biosimilars in the pharmaceutical industry has also increased the need for cell-based assays to test these complex molecules, which often interact with living cells in ways that traditional biochemical assays cannot capture. Technological innovations, such as the development of 3D cell cultures and label-free detection methods, are further fueling market growth by improving the physiological relevance and efficiency of these assays. Moreover, the shift toward personalized medicine is driving demand for assays that can be tailored to individual patients, enabling more precise treatment strategies. In the regulatory landscape, the push to reduce animal testing is accelerating the adoption of cell-based assays in safety and toxicity testing, particularly in industries like cosmetics and chemicals. Finally, the increasing incidence of chronic diseases and cancer is spurring research in disease mechanisms and drug development, further contributing to the growth of the cell-based assay market across healthcare and life sciences industries.

SCOPE OF STUDY:

The report analyzes the Cell Based Assays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Consumables, Instruments, Software, Services); Application (Drug Discovery, ADME Studies, Predictive Toxicology, Other Applications); End-Use (Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Based Assays - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Drug Discovery and Development Propels Growth in Cell-Based Assays
    • Increased Adoption of High-Throughput Screening (HTS) Expands the Addressable Market for Cell-Based Assays
    • Advancements in 3D Cell Cultures Spur Innovation in Cell-Based Assays
    • Rising Focus on Toxicity Testing and Safety Assessment Drives Demand for Cell-Based Assays
    • Shift Towards Biologics and Biosimilars Expands Opportunities in the Cell-Based Assay Market
    • Growing Use of Cell-Based Assays in Oncology Research Generates Increased Market Demand
    • Here's How Automation and Robotics Are Revolutionizing High-Throughput Cell-Based Assays
    • Expanding Applications of Cell-Based Assays in Stem Cell Research Boost Prospects
    • Rising Incidence of Chronic Diseases Spurs the Development of Novel Cell-Based Assays
    • Growing Focus on Real-Time Cell Analysis (RTCA) Strengthens Demand for Innovative Assay Technologies
    • Advances in Label-Free Detection Techniques Propel Growth in the Cell-Based Assay Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Drug discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Drug discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Drug discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ADME Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ADME Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for ADME Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Predictive Toxicology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Predictive Toxicology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Academic & Government Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Academic & Government Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Academic & Government Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Cell Based Assays Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Cell Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Cell Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Cell Based Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Cell Based Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Cell Based Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Cell Based Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Based Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Cell Based Assays by Application - Drug discovery, ADME Studies, Predictive Toxicology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Cell Based Assays by Application - Percentage Breakdown of Value Sales for Drug discovery, ADME Studies, Predictive Toxicology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Cell Based Assays by Component - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Cell Based Assays by Component - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Cell Based Assays by Component - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Cell Based Assays by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Cell Based Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic & Government Institutions and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION